Free Trial

ZIVO Bioscience (NASDAQ:ZIVO) Share Price Crosses Above Fifty Day Moving Average - Here's What Happened

ZIVO Bioscience logo with Medical background

ZIVO Bioscience, Inc. (NASDAQ:ZIVO - Get Free Report)'s stock price passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $16.65 and traded as high as $18.00. ZIVO Bioscience shares last traded at $18.00, with a volume of 5,085 shares.

ZIVO Bioscience Price Performance

The firm has a market capitalization of $68.63 million, a price-to-earnings ratio of -3.69 and a beta of 0.03. The business's fifty day simple moving average is $16.65 and its 200 day simple moving average is $18.81.

About ZIVO Bioscience

(Get Free Report)

ZIVO Bioscience, Inc, a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in ZIVO Bioscience Right Now?

Before you consider ZIVO Bioscience, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ZIVO Bioscience wasn't on the list.

While ZIVO Bioscience currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

New AI Deals Just Sent These 4 Infrastructure Stocks Soaring
7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines